SC 13D

Company

Marker Therapeutics, Inc.

Filed

October 3, 2002

Accession Number

0001050502-02-000835

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →